InvestorsObserver
×
News Home

Do Analysts Agree on BioLife Solutions Inc (BLFS) Stock's Target Price?

Tuesday, September 29, 2020 01:48 PM | InvestorsObserver Analysts

Mentioned in this article

Do Analysts Agree on BioLife Solutions Inc (BLFS) Stock's Target Price?

Analysts who follow BioLife Solutions Inc (BLFS) on average expect it to climb 1.38% over the next twelve months. Those same analysts give the stock an average rating of Strong Buy.

That average rating earns the stock an Analyst Ranking of 63, which means it ranks higher than 63 of stocks, based on data compiled by InvestorsObserver.

Overall Score - 4.5
Wall Street analysts are rating BLFS a Strong Buy today. Find out what this means to you and get the rest of the rankings on BLFS!

Why are Analyst Ratings Important?

A company's financial statements are a significant factor weighted by experts when analyzing a company's health. Beyond just the numbers, analysts follow specific industries closely and are able to gain a detailed understanding of how a storm in one part of the world can shutdown supply chains leading to a change in consumption across the globe. This knowledge allows investors to respond to potential changes in the market before they are revealed in a quarterly annoucement.

Investors Observer averages the ratings across all these analysts and percentile ranks those averages. This allows you to compare stocks in greater detail than the usual five-tiered system used amongst the majority of investors.

What's Happening With BioLife Solutions Inc Stock Today?

BioLife Solutions Inc (BLFS) stock has risen 6.44% while the S&P 500 has fallen -0.42% as of 1:40 PM on Tuesday, Sep 29. BLFS has risen $1.74 from the previous closing price of $27.03 on volume of 221,447 shares. Over the past year the S&P 500 is higher by 12.12% while BLFS has risen 73.00%. BLFS earned $0.13 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 215.49.

Click Here to get the full report on BioLife Solutions Inc (BLFS) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App